Search Results

ADCs are a hot ticket: Major drug companies have been snatching up biotech companies that are developing antibody-drug conjugates (ADCs) targeting a variety of cancers.

• Authors : SUTHERBY, ROSANNA¹

Subjects: *PHARMACEUTICAL industry; ANTIBODY-drug conjugates; PROSTATE-specific membrane antigenUNITED States. Food & Drug Administration

• Source: Managed Healthcare Executive. May2024, Vol. 34 Issue 5, p12-13. 2p.

Record details

Roche Not Alarmed by Obesity Drug's Side Effects, R&D Head Says.

• Authors : Wind, Sonja (AUTHOR); Kresge, Naomi (AUTHOR)

Subjects: *STOCK prices; *INVESTORS; ANTIBODY-drug conjugates

• Source: Bloomberg.com. 9/10/2024, pN.PAG-N.PAG. 1p.

Record details

GSK Inks Lupus Deal With Chinese Biotech for Up to $850 Million.

• Authors : Furlong, Ashleigh (AUTHOR)

Subjects: SYSTEMIC lupus erythematosus; ANTIBODY-drug conjugates; HERPES zoster vaccines

• Source: Bloomberg.com. 10/30/2024, pN.PAG-N.PAG. 1p.

Record details

Daiichi Wants to Go It Alone in Search for Targeted Cancer Drugs.

• Authors : Furlong, Ashleigh (AUTHOR)

Subjects: *CHIEF executive officers; MEDICAL societies; ANTIBODY-drug conjugatesASTRAZENECA PLC ASTRAZENECA PLC ASTRAZENECA PLC AZN

• Source: Bloomberg.com. 9/16/2024, pN.PAG-N.PAG. 1p.

Record details

Comparative Analysis and Future Prospects of Human Epidermal Growth Factor Receptor 2 (HER2) and Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted Antibody-Drug Conjugates in Breast Cancer Treatment

• Authors : Gao, Xiaojuan; Bu, Tiansheng; Wang, Wenying

• Source: Breast Cancer: Targets and Therapy. September 30, 2024, Vol. 16, p621, 10 p.

Record details

Agricola

Record details

Agricola

Record details

Astra Aims to Almost Double Sales to $80 Billion by 2030.

• Authors : Furlong, Ashleigh (AUTHOR)

Subjects: ANTIBODY-drug conjugatesASTRAZENECA PLC ASTRAZENECA PLC ASTRAZENECA PLC AZN

• Source: Bloomberg.com. 5/21/2024, pN.PAG-N.PAG. 1p.

Record details

Dealing with cancer.

Subjects: *PHARMACEUTICAL industry; *MERGERS & acquisitions; ANTIBODY-drug conjugates

• Source: Economist. 9/23/2023, Vol. 448 Issue 9364, p57-58. 2p.

Record details

AstraZeneca Aims for $80 Billion in Sales by 2030.

• Authors : Furlong, Ashleigh (AUTHOR)

Subjects: ANTIBODY-drug conjugatesASTRAZENECA PLC ASTRAZENECA PLC ASTRAZENECA PLC AZN

• Source: Bloomberg.com. 5/21/2024, pN.PAG-N.PAG. 1p.

Record details